Journal of Immunology Research / 2012 / Article / Fig 6

Clinical Study

Immune Modulation in Primary Vaccinia virus Zoonotic Human Infections

Figure 6

Monocyte (CD14+) activation status in PBMCs from individuals infected or not by zoonotic Vaccinia virus. Peripheral blood mononuclear cells (PBMCs) from patients infected or not with zoonotic Vaccinia virus were cultured in the presence of UV-inactivated virus or mock-treated (medium). After 72 hours of stimulus, cells were fixed, counted, and the following parameters were evaluated by flow cytometry using specific mouse anti-human antibodies: (a) percentage of monocytes (CD14+) expressing CD80 surface activation marker; (b) percentage of monocytes (CD14+) expressing CD86 surface activation marker. Statistical significance ( values), based on the median values of each group, is presented on the graphs.
974067.fig.006a
(a)
974067.fig.006b
(b)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.